Daré Bioscience, Inc.

Introduktion

Den här sidan ger en omfattande analys av den kända insiderhandelshistoriken för Stuart A Arbuckle. Insiders är tjänstemän, styrelseledamöter eller betydande investerare i ett företag. Det är olagligt för insiders att göra affärer i sina företag baserat på specifik, icke-offentlig information. Detta betyder inte att det är olagligt för dem att göra några affärer i sina egna företag. De måste dock rapportera alla affärer till SEC via ett formulär 4. Trots dessa restriktioner tyder akademisk forskning på att insiders – i allmänhet – tenderar att överträffa marknaden i sina egna företag.

Genomsnittlig handelslönsamhet

Den genomsnittliga handelslönsamheten är den genomsnittliga avkastningen av alla köp på den öppna marknaden som insidern gjort under de senaste tre åren. För att beräkna detta undersöker vi alla oplanerade köp på öppen marknad som görs av insidern, exklusive alla affärer som markerats som en del av en 10b5-1-handelsplan. Vi beräknar sedan den genomsnittliga prestandan för dessa affärer under 3, 6 och 12 månader, med ett genomsnitt av var och en av dessa varaktigheter för att generera ett slutgiltigt resultatmått för varje affär. Slutligen tar vi ett genomsnitt av alla prestationsmått för att beräkna ett prestationsmått för insidern. Denna lista inkluderar endast insiders som har gjort minst tre affärer under de senaste två åren.

Om lönsamheten för denna insiderhandel är "N/A", så har insidern antingen inte gjort några köp på den öppna marknaden under de senaste tre åren, eller så är affärerna de har gjort för nya för att kunna beräkna ett tillförlitligt resultatmått.

Uppdateringsfrekvens: Dagligen

Se listan över mest lönsamma insiderhandlare

Företag med rapporterade insiderpositioner

SEC-anmälningarna visar att Stuart A Arbuckle har rapporterat innehav eller affärer i följande företag:

Värdepapper Titel Senaste rapporterade innehav
US:VRTX / Vertex Pharmaceuticals Incorporated EVP, COO 63 368
US:RYTM / Rhythm Pharmaceuticals, Inc. Director 7 000
US:IMGN / ImmunoGen, Inc. Director 0
US:CERU / Cerulean Pharma Inc. Director 13 104
Hur man tolkar diagrammen

Följande diagram visar aktieutvecklingen för värdepapper efter varje icke-planerad handel på öppen marknad som görs av Stuart A Arbuckle. Icke-planerad handel är affärer som inte gjordes som en del av en 10b5-1-handelsplan. Aktieutvecklingen visas som kumulativ procentuell förändring av aktiekursen. Till exempel, om en insiderhandel gjordes den 1 januari 2019, kommer diagrammet att visa den dagliga procentuella förändringen av värdepapperet fram till idag. Om aktiekursen skulle gå från $10 till $15 under denna tid, skulle den kumulativa procentuella förändringen i aktiekursen vara 50%. En förändring i priset från 10 USD till 20 USD skulle vara 100 % och en prisändring på 10 USD till 5 USD skulle vara -50 %.

I slutändan försöker vi avgöra hur nära insiders affärer korrelerar med överavkastning (positiv eller negativ) i aktiekursen för att se om insidern tar tid för sina affärer att dra nytta av insiderinformation. Tänk på situationen där en insider gjorde detta. I den här situationen förväntar vi oss antingen (a) positiv avkastning efter köp eller (b) negativ avkastning efter försäljning. I fallet med (a) skulle KÖP-diagrammet visa en serie uppåtlutande kurvor, vilket indikerar positiv avkastning efter varje köptransaktion. I fallet med (b) skulle SALE-diagrammet visa en serie nedåtlutande kurvor, vilket indikerar negativ avkastning efter varje försäljningstransaktion.

Detta är dock inte tillräckligt för att dra slutsatser. Om till exempel aktiekursen i bolaget var i en icke-cyklisk stigning under många år, skulle vi förvänta oss att alla tomter efter köpet skulle vara uppåtlutande. Likaså skulle icke-cykliska nedgångar under många år resultera i nedåtlutande post-trade tomter. Inget av dessa diagram skulle tyda på insiderhandel.

Den starkaste indikatorn skulle vara en situation där aktiekursen var extremt cyklisk, och det fanns både positiva signaler i KÖP-diagrammet och negativa plotter på SALE-diagrammet. Denna situation skulle i hög grad tyda på en insider som tog tid för affärer till sin ekonomiska fördel.

Insiderköp DARE / Daré Bioscience, Inc. - Analys av kortsiktig vinst

I det här avsnittet analyserar vi lönsamheten för varje oplanerat insiderköp på en öppen marknad som görs i DARE / Daré Bioscience, Inc.. Denna analys hjälper till att förstå om insidern konsekvent genererar onormal avkastning och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .

Tabellen nedan visar de senaste öppna marknadsköpen som inte var en del av en automatisk handelsplan.

Handelsdatum Ticker Insider Rapporterade
aktier
Rapporterad
pris
Justerade
aktier
Justerat
pris
Kostnadsgrund Dagar till
max
Pris vid
max
Max
vinst ($)
Maximal avkastning (%)
Det finns inga kända oplanerade öppna marknadstransaktioner för denna insider

Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.

DARE / Daré Bioscience, Inc. Insider Trades
Insiderförsäljning - Analys av kortsiktig förlust

I det här avsnittet analyserar vi det kortsiktiga undvikandet av förluster för varje oplanerad insiderförsäljning på öppen marknad som görs i DARE / Daré Bioscience, Inc.. Ett konsekvent mönster för att undvika förluster kan tyda på att framtida försäljningstransaktioner kan förutsäga prisnedgångar. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .

Följande tabell visar de senaste försäljningarna på den öppna marknaden som inte ingick i en automatisk handelsplan.

Handelsdatum Ticker Insider Rapporterade
aktier
Rapporterad
pris
Justerade
aktier
Justerat
pris
Kostnadsgrund Dagar till
min
Pris vid
min
Maximal förlust
undvikits ($)
Maximal förlust
undvikits ($)
Det finns inga kända oplanerade öppna marknadstransaktioner för denna insider

Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.

DARE / Daré Bioscience, Inc. Insider Trades
Insiderköp RYTM / Rhythm Pharmaceuticals, Inc. - Analys av kortsiktig vinst

I det här avsnittet analyserar vi lönsamheten för varje oplanerat insiderköp på en öppen marknad som görs i DARE / Daré Bioscience, Inc.. Denna analys hjälper till att förstå om insidern konsekvent genererar onormal avkastning och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .

Tabellen nedan visar de senaste öppna marknadsköpen som inte var en del av en automatisk handelsplan.

Handelsdatum Ticker Insider Rapporterade
aktier
Rapporterad
pris
Justerade
aktier
Justerat
pris
Kostnadsgrund Dagar till
max
Pris vid
max
Max
vinst ($)
Maximal avkastning (%)
Det finns inga kända oplanerade öppna marknadstransaktioner för denna insider

Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.

RYTM / Rhythm Pharmaceuticals, Inc. Insider Trades
Insiderförsäljning - Analys av kortsiktig förlust

I det här avsnittet analyserar vi det kortsiktiga undvikandet av förluster för varje oplanerad insiderförsäljning på öppen marknad som görs i DARE / Daré Bioscience, Inc.. Ett konsekvent mönster för att undvika förluster kan tyda på att framtida försäljningstransaktioner kan förutsäga prisnedgångar. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .

Följande tabell visar de senaste försäljningarna på den öppna marknaden som inte ingick i en automatisk handelsplan.

Handelsdatum Ticker Insider Rapporterade
aktier
Rapporterad
pris
Justerade
aktier
Justerat
pris
Kostnadsgrund Dagar till
min
Pris vid
min
Maximal förlust
undvikits ($)
Maximal förlust
undvikits ($)
Det finns inga kända oplanerade öppna marknadstransaktioner för denna insider

Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.

RYTM / Rhythm Pharmaceuticals, Inc. Insider Trades
Insiderhandelshistorik

Den här tabellen visar den fullständiga listan över insideraffärer gjorda av Stuart A Arbuckle som avslöjats för Securities Exchange Commission (SEC).

Fildatum Transaktionsdatum Schema Ticker Värdepapper Kode 10b5-1 Aktier Återstående aktier Procentuell förandring Aktie
pris
Transaktionsvärde Återstående
värde
2025-07-02 2025-07-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
F - Taxes −37 243 63 368 −37,02 450,23 −16 767 916 28 530 175
2025-06-23 2025-06-18 4 RYTM RHYTHM PHARMACEUTICALS, INC.
Common Stock
M - Exercise 4 000 7 000 133,33
2025-05-15 2025-05-13 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 37 622 100 611 59,73
2025-02-28 2025-02-26 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
F - Taxes −7 071 62 935 −10,10 479,61 −3 391 322 30 184 255
2025-02-26 2025-02-24 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
F - Taxes −4 716 70 006 −6,31 483,28 −2 279 148 33 832 500
2025-02-19 2025-02-14 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
F - Taxes −2 724 74 722 −3,52 463,46 −1 262 465 34 630 658
2025-02-14 2025-02-12 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 7 903 77 446 11,36
2025-02-12 2025-02-10 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
F - Taxes −3 220 69 543 −4,43 467,98 −1 506 896 32 544 733
2025-02-06 2025-02-04 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 8 448 72 763 13,14
2025-02-06 2025-02-04 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 14 624 64 315 29,43
2024-06-25 2024-06-21 4 RYTM RHYTHM PHARMACEUTICALS, INC.
Common Stock
M - Exercise 3 000 3 000
2024-05-17 2024-05-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −69 49 691 −0,14 430,93 −29 734 21 413 343
2024-02-27 2024-02-26 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −5 034 49 691 −9,20 425,70 −2 142 974 21 153 459
2024-02-27 2024-02-23 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
F - Taxes −4 714 54 725 −7,93 431,79 −2 035 458 23 629 708
2024-02-23 2024-02-21 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −3 603 59 439 −5,72 421,77 −1 519 637 25 069 587
2024-02-21 2024-02-20 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −4 804 63 042 −7,08 420,79 −2 021 475 26 527 443
2024-02-21 2024-02-20 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
F - Taxes −3 373 67 846 −4,74 420,58 −1 418 616 28 534 671
2024-02-21 2024-02-16 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
F - Taxes −4 499 71 219 −5,94 424,01 −1 907 621 30 197 568
2024-02-13 2024-02-12 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −4 295 75 718 −5,37 420,24 −1 804 931 31 819 732
2024-02-13 2024-02-09 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
F - Taxes −3 177 80 013 −3,82 422,74 −1 343 045 33 824 696
2024-02-12 2024-02-12 4 IMGN ImmunoGen, Inc.
Common Stock
D - Sale to Issuer −5 381 0 −100,00
2024-02-08 2024-02-07 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 8 448 83 190 11,30
2024-02-08 2024-02-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 11 210 74 742 17,64
2024-02-08 2024-02-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 6 976 63 532 12,33
2024-01-03 2023-12-29 4 IMGN ImmunoGen, Inc.
Common Stock
A - Award 442 5 381 8,95 29,65 13 105 159 547
2023-12-15 2023-12-13 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −8 603 56 556 −13,20 399,00 −3 432 597 22 565 844
2023-12-15 2023-12-13 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 8 603 65 159 15,21 187,53 1 613 321 12 219 267
2023-10-02 2023-09-29 4 IMGN ImmunoGen, Inc.
Common Stock
A - Award 827 4 939 20,11 15,87 13 124 78 382
2023-07-05 2023-06-30 4 IMGN ImmunoGen, Inc.
Common Stock
A - Award 695 4 112 20,34 18,87 13 115 77 593
2023-06-20 2023-06-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −8 603 56 556 −13,20 349,00 −3 002 447 19 738 044
2023-06-20 2023-06-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 8 603 65 159 15,21 187,53 1 613 321 12 219 267
2023-06-01 2023-05-30 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −82 56 556 −0,14 329,82 −27 045 18 653 300
2023-04-04 2023-03-31 4 IMGN ImmunoGen, Inc.
Common Stock
A - Award 3 417 3 417 3,84 13 121 13 121
2023-02-28 2023-02-27 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −800 56 556 −1,39 288,92 −231 136 16 340 160
2023-02-28 2023-02-27 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −400 57 356 −0,69 287,59 −115 036 16 495 012
2023-02-28 2023-02-27 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −3 834 57 756 −6,23 287,16 −1 100 971 16 585 213
2023-02-28 2023-02-24 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
F - Taxes −4 714 61 590 −7,11 289,12 −1 362 912 17 806 901
2023-02-24 2023-02-22 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −200 66 304 −0,30 296,31 −59 262 19 646 538
2023-02-24 2023-02-22 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −394 66 504 −0,59 295,38 −116 380 19 643 952
2023-02-24 2023-02-22 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −1 378 66 898 −2,02 294,29 −405 532 19 687 412
2023-02-24 2023-02-22 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −300 68 276 −0,44 292,86 −87 858 19 995 309
2023-02-24 2023-02-22 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −129 68 576 −0,19 291,84 −37 647 20 013 220
2023-02-22 2023-02-21 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −736 68 705 −1,06 294,58 −216 811 20 239 119
2023-02-22 2023-02-21 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −1 100 69 441 −1,56 293,74 −323 114 20 397 599
2023-02-22 2023-02-21 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −545 70 541 −0,77 292,77 −159 560 20 652 289
2023-02-22 2023-02-21 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −21 71 086 −0,03 291,01 −6 111 20 686 737
2023-02-22 2023-02-17 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
F - Taxes −4 498 71 107 −5,95 292,85 −1 317 239 20 823 685
2023-02-16 2023-02-14 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −400 75 605 −0,53 300,89 −120 356 22 748 788
2023-02-16 2023-02-14 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −1 734 76 005 −2,23 300,09 −520 356 22 808 340
2023-02-16 2023-02-14 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −2 003 77 739 −2,51 299,13 −599 157 23 254 067
2023-02-16 2023-02-14 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −560 79 742 −0,70 298,14 −166 958 23 774 280
2023-02-16 2023-02-14 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −901 80 302 −1,11 296,85 −267 462 23 837 649
2023-02-16 2023-02-14 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −800 81 203 −0,98 295,84 −236 672 24 023 096
2023-02-14 2023-02-13 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −835 82 003 −1,01 300,13 −250 609 24 611 560
2023-02-14 2023-02-13 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −1 779 82 838 −2,10 299,26 −532 384 24 790 100
2023-02-14 2023-02-13 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −2 028 84 617 −2,34 298,42 −605 196 25 251 405
2023-02-14 2023-02-13 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −245 86 645 −0,28 296,44 −72 628 25 685 044
2023-02-14 2023-02-13 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
F - Taxes −5 990 86 890 −6,45 298,26 −1 786 577 25 915 811
2023-02-14 2023-02-10 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
F - Taxes −3 372 92 880 −3,50 294,33 −992 481 27 337 370
2023-02-03 2023-02-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 11 209 96 252 13,18
2023-02-03 2023-02-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 14 624 85 043 20,77
2023-02-03 2023-02-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 12 388 70 419 21,35
2022-12-08 2022-12-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 12 753 58 031 28,17
2022-08-17 2022-08-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −6 948 45 278 −13,30 305,38 −2 121 780 13 826 996
2022-08-17 2022-08-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −6 990 52 226 −11,80 304,67 −2 129 643 15 911 695
2022-08-17 2022-08-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −2 339 59 216 −3,80 303,78 −710 541 17 988 636
2022-08-17 2022-08-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −400 61 555 −0,65 302,55 −121 020 18 623 465
2022-08-17 2022-08-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −4 242 61 955 −6,41 301,61 −1 279 430 18 686 248
2022-08-17 2022-08-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −1 254 66 197 −1,86 300,30 −376 576 19 878 959
2022-08-17 2022-08-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 6 571 67 451 10,79 155,57 1 022 250 10 493 352
2022-08-12 2022-08-10 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −9 60 880 −0,01 302,01 −2 718 18 386 369
2022-08-12 2022-08-10 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −171 60 889 −0,28 300,32 −51 355 18 286 184
2022-08-12 2022-08-10 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 64 61 060 0,10 155,57 9 956 9 499 104
2022-08-10 2022-08-09 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −900 60 996 −1,45 301,42 −271 278 18 385 414
2022-08-10 2022-08-09 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −4 790 61 896 −7,18 300,53 −1 439 539 18 601 605
2022-08-10 2022-08-09 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 1 926 66 686 2,97 155,57 299 628 10 374 341
2022-05-18 2022-05-16 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −40 64 760 −0,06 254,19 −10 168 16 461 344
2022-05-18 2022-05-16 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −10 64 800 −0,02 252,66 −2 527 16 372 368
2022-05-18 2022-05-16 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −10 64 810 −0,02 251,43 −2 514 16 295 178
2022-05-18 2022-05-16 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −32 64 820 −0,05 250,78 −8 025 16 255 560
2022-05-18 2022-05-16 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −20 64 852 −0,03 249,35 −4 987 16 170 846
2022-05-18 2022-05-16 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −10 64 872 −0,02 247,95 −2 480 16 085 012
2022-05-18 2022-05-16 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −11 64 882 −0,02 246,21 −2 708 15 974 597
2022-05-04 2022-05-02 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −306 64 760 −0,47 263,98 −80 778 17 095 345
2022-02-28 2022-02-24 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
F - Taxes −7 246 65 066 −10,02 227,86 −1 651 074 14 825 939
2022-02-22 2022-02-17 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
F - Taxes −4 126 72 312 −5,40 232,51 −959 336 16 813 263
2022-02-14 2022-02-10 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
F - Taxes −3 040 76 438 −3,82 237,74 −722 730 18 172 370
2022-02-03 2022-02-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 14 623 79 478 22,55
2022-02-03 2022-02-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 13 952 64 855 27,41
2022-02-03 2022-02-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 9 800 50 903 23,84
2021-11-16 2021-11-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −1 41 103 0,00 187,80 −188 7 719 143
2021-11-16 2021-11-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −2 41 104 0,00 186,99 −374 7 686 037
2021-06-17 2021-06-16 4 IMGN ImmunoGen, Inc.
Stock Option (right to buy)
A - Award 44 000 44 000 6,77 297 880 297 880
2021-06-17 2021-06-16 4 IMGN ImmunoGen, Inc.
Deferred Share Unit
A - Award 15 000 48 000 45,45
2021-06-11 2021-06-09 4 RYTM RHYTHM PHARMACEUTICALS, INC.
Stock Option (right to buy)
A - Award 15 000 15 000
2021-05-19 2021-05-17 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −16 41 103 −0,04 217,15 −3 474 8 925 516
2021-05-19 2021-05-17 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −86 41 119 −0,21 216,36 −18 607 8 896 507
2021-05-19 2021-05-17 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −7 41 205 −0,02 215,33 −1 507 8 872 673
2021-02-26 2021-02-25 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −254 41 103 −0,61 216,57 −55 009 8 901 677
2021-02-26 2021-02-25 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −300 41 357 −0,72 215,62 −64 686 8 917 396
2021-02-26 2021-02-25 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −400 41 657 −0,95 214,32 −85 728 8 927 928
2021-02-26 2021-02-25 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −1 400 42 057 −3,22 213,55 −298 970 8 981 272
2021-02-26 2021-02-25 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −900 43 457 −2,03 212,52 −191 268 9 235 482
2021-02-26 2021-02-25 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −380 44 357 −0,85 211,39 −80 328 9 376 626
2021-02-26 2021-02-24 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
F - Taxes −2 898 44 737 −6,08 217,57 −630 518 9 733 429
2021-02-19 2021-02-18 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −100 47 635 −0,21 213,26 −21 326 10 158 640
2021-02-19 2021-02-18 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −2 763 47 735 −5,47 212,49 −587 110 10 143 210
2021-02-19 2021-02-18 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −3 940 50 498 −7,24 211,77 −834 374 10 693 961
2021-02-19 2021-02-18 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −1 022 54 438 −1,84 210,05 −214 671 11 434 702
2021-02-19 2021-02-17 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
F - Taxes −6 240 55 460 −10,11 211,75 −1 321 320 11 743 655
2021-02-16 2021-02-11 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −200 61 700 −0,32 212,10 −42 420 13 086 570
2021-02-16 2021-02-11 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −600 61 900 −0,96 211,19 −126 714 13 072 661
2021-02-16 2021-02-11 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −4 356 62 500 −6,52 210,39 −916 459 13 149 375
2021-02-12 2021-02-10 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
F - Taxes −3 101 66 856 −4,43 214,16 −664 110 14 317 881
2021-02-05 2021-02-03 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
M - Exercise −1 554 0 −100,00
2021-02-05 2021-02-03 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −89 69 957 −0,13 216,83 −19 298 15 168 776
2021-02-05 2021-02-03 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −90 70 046 −0,13 215,80 −19 422 15 115 927
2021-02-05 2021-02-03 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −242 70 136 −0,34 214,98 −52 025 15 077 837
2021-02-05 2021-02-03 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −497 70 378 −0,70 213,90 −106 308 15 053 854
2021-02-05 2021-02-03 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −488 70 875 −0,68 212,77 −103 832 15 080 074
2021-02-05 2021-02-03 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −148 71 363 −0,21 211,22 −31 261 15 073 293
2021-02-05 2021-02-03 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 1 554 71 511 2,22 86,52 134 452 6 187 132
2021-02-05 2021-02-03 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 13 952 69 957 24,91
2021-02-05 2021-02-03 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 12 388 56 005 28,40
2021-02-05 2021-02-03 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 8 438 43 617 23,99
2020-11-18 2020-11-16 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −5 35 179 −0,01 224,11 −1 121 7 883 966
2020-11-18 2020-11-16 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −2 35 184 −0,01 222,47 −445 7 827 384
2020-11-05 2020-11-03 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
M - Exercise −1 553 1 554 −49,98
2020-11-05 2020-11-03 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −334 35 179 −0,94 214,13 −71 519 7 532 879
2020-11-05 2020-11-03 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −245 35 513 −0,69 212,38 −52 033 7 542 251
2020-11-05 2020-11-03 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −487 35 758 −1,34 211,54 −103 020 7 564 247
2020-11-05 2020-11-03 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −487 36 245 −1,33 210,56 −102 543 7 631 747
2020-11-05 2020-11-03 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 1 553 36 732 4,41 86,52 134 366 3 178 053
2020-08-05 2020-08-03 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
M - Exercise −1 553 3 107 −33,33
2020-08-05 2020-08-03 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −280 35 179 −0,79 279,58 −78 282 9 835 345
2020-08-05 2020-08-03 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −689 35 459 −1,91 278,72 −192 038 9 883 132
2020-08-05 2020-08-03 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −413 36 148 −1,13 277,85 −114 752 10 043 722
2020-08-05 2020-08-03 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −171 36 561 −0,47 276,40 −47 264 10 105 460
2020-08-05 2020-08-03 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 1 553 36 732 4,41 86,52 134 366 3 178 053
2020-07-09 2020-07-07 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to buy)
M - Exercise −1 222 8 561 −12,49
2020-07-09 2020-07-07 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to buy)
M - Exercise −1 564 17 206 −8,33
2020-07-09 2020-07-07 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −2 786 35 179 −7,34 300,00 −835 800 10 553 700
2020-07-09 2020-07-07 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 1 222 37 965 3,33 155,57 190 107 5 906 215
2020-07-09 2020-07-07 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 1 564 36 743 4,45 187,53 293 297 6 890 415
2020-06-18 2020-06-17 4 RYTM RHYTHM PHARMACEUTICALS, INC.
Stock Option (right to buy)
A - Award 18 500 18 500
2020-06-18 2020-06-17 4 IMGN ImmunoGen, Inc.
Stock Option (right to buy)
A - Award 50 000 50 000 4,56 228 000 228 000
2020-06-18 2020-06-17 4 IMGN ImmunoGen, Inc.
Deferred Share Unit
A - Award 17 000 33 000 106,25
2020-05-19 2020-05-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −9 35 179 −0,03 288,35 −2 595 10 143 865
2020-05-19 2020-05-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −24 35 188 −0,07 287,62 −6 903 10 120 773
2020-05-19 2020-05-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −21 35 212 −0,06 286,41 −6 015 10 085 069
2020-05-19 2020-05-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −10 35 233 −0,03 285,00 −2 850 10 041 405
2020-05-19 2020-05-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −10 35 243 −0,03 283,58 −2 836 9 994 210
2020-05-19 2020-05-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −12 35 253 −0,03 280,71 −3 369 9 895 870
2020-05-19 2020-05-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −17 35 265 −0,05 279,93 −4 759 9 871 731
2020-05-19 2020-05-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −10 35 282 −0,03 276,35 −2 764 9 750 181
2020-05-06 2020-05-04 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
M - Exercise −1 553 4 660 −25,00
2020-05-06 2020-05-04 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −113 35 179 −0,32 264,89 −29 933 9 318 565
2020-05-06 2020-05-04 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −240 35 292 −0,68 262,54 −63 010 9 265 562
2020-05-06 2020-05-04 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −240 35 532 −0,67 261,34 −62 722 9 285 933
2020-05-06 2020-05-04 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −320 35 772 −0,89 260,32 −83 302 9 312 167
2020-05-06 2020-05-04 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −640 36 092 −1,74 259,36 −165 990 9 360 821
2020-05-06 2020-05-04 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 1 553 36 732 4,41 86,52 134 366 3 178 053
2020-02-26 2020-02-25 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −632 35 179 −1,76 238,33 −150 625 8 384 211
2020-02-26 2020-02-25 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −20 35 811 −0,06 236,88 −4 738 8 482 910
2020-02-26 2020-02-25 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −420 35 831 −1,16 236,36 −99 271 8 469 015
2020-02-26 2020-02-25 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −540 36 251 −1,47 235,14 −126 976 8 524 060
2020-02-26 2020-02-25 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −420 36 791 −1,13 234,08 −98 314 8 612 037
2020-02-26 2020-02-25 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −360 37 211 −0,96 232,35 −83 646 8 645 976
2020-02-26 2020-02-25 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −432 37 571 −1,14 230,85 −99 727 8 673 265
2020-02-26 2020-02-25 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −810 38 003 −2,09 229,78 −186 122 8 732 329
2020-02-26 2020-02-24 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
F - Taxes −2 898 38 813 −6,95 239,23 −693 289 9 285 234
2020-02-19 2020-02-18 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −377 41 711 −0,90 245,76 −92 652 10 250 895
2020-02-19 2020-02-18 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −580 42 088 −1,36 245,04 −142 123 10 313 244
2020-02-19 2020-02-18 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −400 42 668 −0,93 243,76 −97 504 10 400 752
2020-02-19 2020-02-18 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −1 011 43 068 −2,29 242,91 −245 582 10 461 648
2020-02-19 2020-02-18 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −760 44 079 −1,69 242,08 −183 981 10 670 644
2020-02-19 2020-02-17 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
F - Taxes −2 496 44 839 −5,27 241,50 −602 784 10 828 618
2020-02-12 2020-02-11 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −486 47 335 −1,02 248,62 −120 829 11 768 428
2020-02-12 2020-02-11 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −1 863 47 821 −3,75 247,91 −461 856 11 855 304
2020-02-12 2020-02-11 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −1 770 49 684 −3,44 246,76 −436 765 12 260 024
2020-02-12 2020-02-11 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −3 377 51 454 −6,16 245,93 −830 506 12 654 082
2020-02-12 2020-02-11 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −2 860 54 831 −4,96 244,99 −700 671 13 433 047
2020-02-12 2020-02-11 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −930 57 691 −1,59 243,76 −226 697 14 062 758
2020-02-12 2020-02-10 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
F - Taxes −8 942 58 621 −13,24 240,95 −2 154 575 14 124 730
2020-02-07 2020-02-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
M - Exercise −1 223 9 783 −11,11
2020-02-07 2020-02-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
M - Exercise −1 564 18 770 −7,69
2020-02-07 2020-02-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −171 67 563 −0,25 242,47 −41 462 16 382 001
2020-02-07 2020-02-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −150 67 734 −0,22 241,08 −36 162 16 329 313
2020-02-07 2020-02-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −230 67 884 −0,34 240,53 −55 322 16 328 139
2020-02-07 2020-02-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −725 68 114 −1,05 239,47 −173 616 16 311 260
2020-02-07 2020-02-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −1 511 68 839 −2,15 238,71 −360 691 16 432 558
2020-02-07 2020-02-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 1 223 70 350 1,77 155,57 190 262 10 944 350
2020-02-07 2020-02-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 1 564 69 127 2,31 187,53 293 297 12 963 386
2020-02-07 2020-02-05 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 12 387 67 563 22,45
2020-02-07 2020-02-05 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 9 800 55 176 21,60
2020-02-07 2020-02-05 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 12 136 45 376 36,51
2020-02-04 2020-02-03 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
M - Exercise −1 554 6 213 −20,01
2020-02-04 2020-02-03 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
M - Exercise −2 156 0 −100,00
2020-02-04 2020-02-03 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −540 33 240 −1,60 232,71 −125 663 7 735 280
2020-02-04 2020-02-03 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −900 33 780 −2,60 231,87 −208 683 7 832 569
2020-02-04 2020-02-03 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −1 300 34 680 −3,61 231,16 −300 508 8 016 629
2020-02-04 2020-02-03 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −530 35 980 −1,45 229,99 −121 895 8 275 040
2020-02-04 2020-02-03 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −440 36 510 −1,19 228,90 −100 716 8 357 139
2020-02-04 2020-02-03 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise −1 554 36 950 −4,04 86,52 −134 452 3 196 914
2020-02-04 2020-02-03 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise −2 156 35 396 −5,74 91,05 −196 304 3 222 806
2020-02-04 2020-01-31 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
M - Exercise −4 692 20 334 −18,75
2020-02-04 2020-01-31 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −4 692 33 240 −12,37 238,65 −1 119 746 7 932 726
2020-02-04 2020-01-31 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 4 692 37 932 14,12 187,53 879 891 7 113 388
2019-11-19 2019-11-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −19 33 240 −0,06 205,95 −3 913 6 845 778
2019-11-15 2019-11-13 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
M - Exercise −8 560 11 006 −43,75
2019-11-15 2019-11-13 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −8 560 33 240 −20,48 205,57 −1 759 679 6 833 147
2019-11-15 2019-11-13 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 8 560 41 800 25,75 155,57 1 331 679 6 502 826
2019-11-06 2019-11-04 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
M - Exercise −1 553 7 767 −16,66
2019-11-06 2019-11-04 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
M - Exercise −2 155 2 156 −49,99
2019-11-06 2019-11-04 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −1 553 33 240 −4,46 201,62 −313 116 6 701 849
2019-11-06 2019-11-04 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 1 553 34 793 4,67 86,52 134 366 3 010 290
2019-11-06 2019-11-04 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale −2 155 33 240 −6,09 201,62 −434 491 6 701 849
2019-11-06 2019-11-04 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 2 155 35 395 6,48 91,05 196 213 3 222 715
2019-08-12 2019-08-08 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
M - Exercise 2 125 0 −100,00
2019-08-12 2019-08-08 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −2 125 33 240 −6,01 181,89 −386 516 6 046 024
2019-08-12 2019-08-08 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 2 125 35 365 6,39 131,89 280 266 4 664 290
2019-08-06 2019-08-05 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
M - Exercise 1 553 9 320 19,99
2019-08-06 2019-08-05 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −1 553 32 240 −4,60 176,44 −274 011 5 688 426
2019-08-06 2019-08-05 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 1 553 33 793 4,82 86,52 134 366 2 923 770
2019-08-06 2019-08-02 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
M - Exercise 2 155 4 311 99,95
2019-08-06 2019-08-02 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −2 155 32 240 −6,27 177,78 −383 116 5 731 627
2019-08-06 2019-08-02 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 2 155 34 395 6,68 91,05 196 213 3 131 665
2019-08-01 2019-07-30 4 RYTM RHYTHM PHARMACEUTICALS, INC.
Stock Option (right to buy)
A - Award 30 000 30 000
2019-06-24 2019-06-20 4 IMGN IMMUNOGEN INC
Stock Option (right to buy)
A - Award 18 000 18 000 2,10 37 800 37 800
2019-06-24 2019-06-20 4 IMGN IMMUNOGEN INC
Deferred Share Unit
A - Award 4 000 16 000 33,33
2019-06-20 2019-06-19 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
M - Exercise −2 125 2 125 −50,00
2019-06-20 2019-06-19 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −2 125 33 240 −6,01 181,89 −386 516 6 046 024
2019-06-20 2019-06-19 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 2 125 35 365 6,39 131,89 280 266 4 664 290
2019-05-17 2019-05-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −133 33 240 −0,40 165,41 −22 000 5 498 228
2019-05-06 2019-05-03 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
M - Exercise 1 553 10 873 16,66
2019-05-06 2019-05-03 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −593 33 240 −1,75 173,60 −102 945 5 770 464
2019-05-06 2019-05-03 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −400 33 833 −1,17 172,73 −69 092 5 843 974
2019-05-06 2019-05-03 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −320 34 233 −0,93 171,31 −54 819 5 864 455
2019-05-06 2019-05-03 4 VRTX VERTEX PHARMACEUTICALS INC / MA
CommonStock
S - Sale X −240 34 553 −0,69 170,28 −40 867 5 883 685
2019-05-06 2019-05-03 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 1 553 34 793 4,67 86,52 134 366 3 010 290
2019-05-06 2019-05-02 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
M - Exercise 2 155 6 466 49,99
2019-05-06 2019-05-02 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −100 33 240 −0,30 171,70 −17 170 5 707 308
2019-05-06 2019-05-02 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −400 33 340 −1,19 170,72 −68 288 5 691 805
2019-05-06 2019-05-02 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −457 33 740 −1,34 169,31 −77 375 5 712 519
2019-05-06 2019-05-02 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −1 198 34 197 −3,38 168,56 −201 935 5 764 246
2019-05-06 2019-05-02 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 2 155 35 395 6,48 91,05 196 213 3 222 715
2019-04-17 2019-04-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −320 33 240 −0,95 183,61 −58 755 6 103 196
2019-04-17 2019-04-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −2 712 33 560 −7,48 182,29 −494 370 6 117 652
2019-04-17 2019-04-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −2 592 36 272 −6,67 180,95 −469 022 6 563 418
2019-02-13 2019-02-11 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −7 501 38 864 −16,18 181,03 −1 357 906 7 035 550
2019-02-13 2019-02-11 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −14 915 46 365 −24,34 180,34 −2 689 771 8 361 464
2019-02-13 2019-02-11 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −10 657 61 280 −14,81 179,44 −1 912 292 10 996 083
2019-02-08 2019-02-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
A - Award 25 026 25 026
2019-02-08 2019-02-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 9 799 71 937 15,77
2019-02-08 2019-02-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 8 438 62 138 15,71
2019-02-08 2019-02-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 17 298 53 700 47,52
2019-02-06 2019-02-04 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
M - Exercise 1 554 12 426 14,29
2019-02-06 2019-02-04 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
M - Exercise 2 155 8 621 33,33
2019-02-06 2019-02-04 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
M - Exercise 4 250 0 −100,00
2019-02-06 2019-02-04 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −300 36 402 −0,82 188,07 −56 421 6 846 124
2019-02-06 2019-02-04 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −4 044 36 702 −9,92 186,84 −755 581 6 857 402
2019-02-06 2019-02-04 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −12 565 40 746 −23,57 186,10 −2 338 346 7 582 831
2019-02-06 2019-02-04 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −1 400 53 311 −2,56 184,81 −258 734 9 852 406
2019-02-06 2019-02-04 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 1 554 54 711 2,92 86,52 134 452 4 733 596
2019-02-06 2019-02-04 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 2 155 53 157 4,23 91,05 196 213 4 839 945
2019-02-06 2019-02-04 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 4 250 51 002 9,09 109,41 464 992 5 580 129
2019-01-24 2019-01-22 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
M - Exercise −2 125 4 250 −33,33
2019-01-24 2019-01-22 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −2 125 46 752 −4,35 193,48 −411 145 9 045 577
2019-01-24 2019-01-22 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 2 125 48 877 4,55 131,89 280 266 6 446 388
2018-11-19 2018-11-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −29 46 752 −0,06 163,75 −4 749 7 655 640
2018-11-08 2018-11-07 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
M - Exercise 2 125 6 375 50,00
2018-11-08 2018-11-07 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −2 125 46 752 −4,35 179,00 −380 375 8 368 608
2018-11-08 2018-11-07 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 2 125 48 877 4,55 131,89 280 266 6 446 388
2018-11-06 2018-11-05 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
M - Exercise 1 553 13 980 12,50
2018-11-06 2018-11-05 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
M - Exercise 4 250 4 250
2018-11-06 2018-11-05 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −1 553 46 752 −3,21 172,08 −267 240 8 045 084
2018-11-06 2018-11-05 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 1 553 48 305 3,32 86,52 134 366 4 179 349
2018-11-06 2018-11-05 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −4 250 46 752 −8,33 172,08 −731 340 8 045 084
2018-11-06 2018-11-05 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 4 250 51 002 9,09 109,14 463 845 5 566 358
2018-11-05 2018-11-02 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
M - Exercise 2 155 10 776 25,00
2018-11-05 2018-11-02 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −2 155 46 752 −4,41 175,36 −377 901 8 198 431
2018-11-05 2018-11-02 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 2 155 48 907 4,61 91,05 196 213 4 452 982
2018-08-06 2018-08-03 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
M - Exercise −1 553 15 533 −9,09
2018-08-06 2018-08-03 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
M - Exercise −4 250 8 500 −33,33
2018-08-06 2018-08-03 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −5 803 46 752 −11,04 174,20 −1 010 883 8 144 198
2018-08-06 2018-08-03 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 1 553 52 555 3,04 86,52 134 366 4 547 059
2018-08-06 2018-08-03 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 4 250 51 002 9,09 109,14 463 845 5 566 358
2018-08-06 2018-08-02 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
M - Exercise −2 155 12 931 −14,28
2018-08-06 2018-08-02 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
M - Exercise −2 125 8 500 −20,00
2018-08-06 2018-08-02 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −2 155 46 752 −4,41 174,59 −376 241 8 162 432
2018-08-06 2018-08-02 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 2 155 48 907 4,61 91,05 196 213 4 452 982
2018-08-06 2018-08-02 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −2 125 46 752 −4,35 179,00 −380 375 8 368 608
2018-08-06 2018-08-02 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 2 125 48 877 4,55 131,89 280 266 6 446 388
2018-07-17 2018-07-16 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
M - Exercise −2 125 0 −100,00
2018-07-17 2018-07-16 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −2 125 46 752 −4,35 179,85 −382 181 8 408 347
2018-07-17 2018-07-16 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 2 125 48 877 4,55 96,87 205 849 4 734 715
2018-07-17 2018-07-13 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
M - Exercise −6 375 10 625 −37,50
2018-07-17 2018-07-13 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −6 375 46 752 −12,00 179,00 −1 141 125 8 368 608
2018-07-17 2018-07-13 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 6 375 53 127 13,64 131,89 840 799 7 006 920
2018-07-03 2018-06-29 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
M - Exercise −1 553 17 086 −8,33
2018-07-03 2018-06-29 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
M - Exercise −2 155 15 086 −12,50
2018-07-03 2018-06-29 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −3 708 46 752 −7,35 169,00 −626 652 7 901 088
2018-07-03 2018-06-29 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 1 553 50 460 3,18 86,52 134 366 4 365 799
2018-07-03 2018-06-29 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 2 155 48 907 4,61 91,05 196 213 4 452 982
2018-06-26 2018-06-22 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
M - Exercise −4 250 12 750 −25,00
2018-06-26 2018-06-22 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −4 250 46 752 −8,33 159,00 −675 750 7 433 568
2018-06-26 2018-06-22 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 4 250 51 002 9,09 109,14 463 845 5 566 358
2018-06-22 2018-06-20 4 IMGN IMMUNOGEN INC
Stock option (right to buy)
A - Award 15 800 15 800 11,21 177 118 177 118
2018-06-22 2018-06-20 4 IMGN IMMUNOGEN INC
Deferred Share Unit
A - Award 1 500 12 000 14,29
2018-06-22 2018-06-20 4 IMGN IMMUNOGEN INC
Stock option (right to buy)
A - Award 18 000 18 000 11,21 201 780 201 780
2018-06-22 2018-06-20 4 IMGN IMMUNOGEN INC
Deferred Share Unit
A - Award 4 000 10 500 61,54
2018-05-16 2018-05-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −138 46 752 −0,29 155,78 −21 498 7 283 027
2018-04-18 2018-04-16 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
M - Exercise −2 125 2 125 −50,00
2018-04-18 2018-04-16 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −2 125 46 752 −4,35 163,01 −346 396 7 621 044
2018-04-18 2018-04-16 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 2 125 48 877 4,55 96,87 205 849 4 734 715
2018-02-28 2018-02-26 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
M - Exercise −1 554 18 639 −7,70
2018-02-28 2018-02-26 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −6 459 46 752 −12,14 169,00 −1 091 571 7 901 088
2018-02-28 2018-02-26 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 1 554 53 211 3,01 86,52 134 452 4 603 816
2018-02-15 2018-02-13 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −2 022 51 657 −3,77 152,26 −307 870 7 865 295
2018-02-15 2018-02-13 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −2 022 53 679 −3,63 151,40 −306 131 8 127 001
2018-02-14 2018-02-12 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −1 270 55 701 −2,23 153,80 −195 326 8 566 814
2018-02-14 2018-02-12 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −3 879 56 971 −6,37 153,07 −593 759 8 720 551
2018-02-14 2018-02-12 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −800 60 850 −1,30 152,27 −121 816 9 265 630
2018-02-14 2018-02-12 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −875 61 650 −1,40 150,78 −131 932 9 295 587
2018-02-08 2018-02-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
A - Award 19 566 19 566
2018-02-08 2018-02-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 8 437 62 525 15,60
2018-02-08 2018-02-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 12 136 54 088 28,93
2018-02-07 2018-02-05 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
M - Exercise −4 250 17 000 −20,00
2018-02-07 2018-02-05 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
M - Exercise −4 250 17 000 −20,00
2018-02-07 2018-02-05 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −8 500 41 952 −16,85 163,08 −1 386 180 6 841 532
2018-02-07 2018-02-05 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 4 250 50 452 9,20 109,14 463 845 5 506 331
2018-02-07 2018-02-05 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 4 250 46 202 10,13 77,31 328 568 3 571 877
2018-02-05 2018-02-02 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
M - Exercise −2 156 17 241 −11,12
2018-02-05 2018-02-02 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −2 156 41 952 −4,89 169,42 −365 270 7 107 508
2018-02-05 2018-02-02 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 2 156 44 108 5,14 91,05 196 304 4 016 033
2018-01-26 2018-01-24 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
M - Exercise −4 659 20 193 −18,75
2018-01-26 2018-01-24 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
M - Exercise −4 310 19 397 −18,18
2018-01-26 2018-01-24 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −8 969 41 952 −17,61 169,00 −1 515 761 7 089 888
2018-01-26 2018-01-24 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 4 659 50 921 10,07 86,52 403 097 4 405 685
2018-01-26 2018-01-24 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 4 310 46 262 10,27 91,05 392 426 4 212 155
2018-01-17 2018-01-16 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
M - Exercise −2 125 4 250 −33,33
2018-01-17 2018-01-16 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −2 125 41 952 −4,82 158,28 −336 345 6 640 163
2018-01-17 2018-01-16 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 2 125 44 077 5,07 96,87 205 849 4 269 739
2018-01-12 2018-01-11 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
M - Exercise −4 250 21 250 −16,67
2018-01-12 2018-01-11 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −4 250 41 952 −9,20 159,00 −675 750 6 670 368
2018-01-12 2018-01-11 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 4 250 46 202 10,13 109,14 463 845 5 042 486
2017-12-06 2017-11-15 4/A VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −48 41 952 −0,11 147,29 −7 070 6 179 110
2017-11-17 2017-11-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −221 41 952 −0,52 147,29 −32 551 6 179 110
2017-11-07 2017-11-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
M - Exercise −4 250 4 250 −50,00
2017-11-07 2017-11-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −4 250 41 952 −9,20 148,17 −629 722 6 216 028
2017-11-07 2017-11-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 4 250 46 202 10,13 77,31 328 568 3 571 877
2017-10-31 2017-10-31 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −500 41 952 −1,18 149,34 −74 670 6 265 112
2017-10-31 2017-10-31 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −1 000 42 452 −2,30 148,54 −148 540 6 305 820
2017-10-31 2017-10-31 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −5 000 43 452 −10,32 147,87 −739 350 6 425 247
2017-10-31 2017-10-31 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −7 783 48 452 −13,84 146,61 −1 141 066 7 103 548
2017-10-31 2017-10-31 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −17 501 56 235 −23,73 145,34 −2 543 595 8 173 195
2017-10-31 2017-10-31 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −25 999 73 736 −26,07 144,54 −3 757 895 10 657 801
2017-10-31 2017-10-31 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −5 600 99 735 −5,32 143,54 −803 824 14 315 962
2017-10-31 2017-10-31 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −11 617 105 335 −9,93 142,18 −1 651 705 14 976 530
2017-10-31 2017-10-27 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
M - Exercise −2 125 6 375 −25,00
2017-10-31 2017-10-27 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −2 125 116 952 −1,78 149,00 −316 625 17 425 848
2017-10-31 2017-10-27 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 2 125 119 077 1,82 96,87 205 849 11 534 989
2017-10-31 2017-10-27 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −4 165 116 952 −3,44 141,41 −588 973 16 538 182
2017-08-09 2017-08-07 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
M - Exercise −4 250 8 500 −33,33
2017-08-09 2017-08-07 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −4 250 121 117 −3,39 152,88 −649 740 18 516 367
2017-08-09 2017-08-07 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 4 250 125 367 3,51 77,31 328 568 9 692 123
2017-08-04 2017-08-03 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
M - Exercise −4 250 25 500 −14,29
2017-08-04 2017-08-03 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −4 250 121 117 −3,39 155,72 −661 810 18 860 339
2017-08-04 2017-08-03 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 4 250 125 367 3,51 109,14 463 845 13 682 554
2017-08-02 2017-07-31 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
M - Exercise −2 125 0 −100,00
2017-08-02 2017-07-31 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −2 125 121 117 −1,72 152,99 −325 104 18 529 690
2017-08-02 2017-07-31 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 2 125 123 242 1,75 83,36 177 140 10 273 453
2017-07-21 2017-07-21 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
M - Exercise −2 125 17 000 −11,11
2017-07-21 2017-07-21 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −200 121 117 −0,16 161,72 −32 344 19 587 041
2017-07-21 2017-07-21 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −10 150 121 317 −7,72 161,68 −1 641 052 19 614 533
2017-07-21 2017-07-21 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −2 125 131 467 −1,59 159,00 −337 875 20 903 253
2017-07-21 2017-07-21 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 2 125 133 592 1,62 131,89 280 266 17 619 449
2017-07-21 2017-07-19 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
M - Exercise −10 775 23 707 −31,25
2017-07-21 2017-07-19 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
M - Exercise −14 875 19 125 −43,75
2017-07-21 2017-07-19 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
M - Exercise −38 250 38 250 −50,00
2017-07-21 2017-07-19 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
M - Exercise −25 500 8 500 −75,00
2017-07-21 2017-07-19 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −29 000 131 467 −18,07 162,67 −4 717 430 21 385 737
2017-07-21 2017-07-19 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −60 400 160 467 −27,35 161,00 −9 724 400 25 835 187
2017-07-21 2017-07-19 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 10 775 220 867 5,13 91,05 981 064 20 109 940
2017-07-21 2017-07-19 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 14 875 210 092 7,62 131,89 1 961 864 27 709 034
2017-07-21 2017-07-19 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 38 250 195 217 24,37 109,14 4 174 605 21 305 983
2017-07-21 2017-07-19 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 25 500 156 967 19,40 96,87 2 470 185 15 205 393
2017-06-05 2017-06-02 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
M - Exercise −31 875 2 125 −93,75
2017-06-05 2017-06-02 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
M - Exercise −25 500 12 750 −66,67
2017-06-05 2017-06-02 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −57 375 131 467 −30,38 129,02 −7 402 522 16 961 872
2017-06-05 2017-06-02 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 31 875 188 842 20,31 83,36 2 657 100 15 741 869
2017-06-05 2017-06-02 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 25 500 156 967 19,40 77,31 1 971 405 12 135 119
2017-06-05 2017-06-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
M - Exercise −13 594 0 −100,00
2017-06-05 2017-06-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −13 594 131 467 −9,37 124,00 −1 685 656 16 301 908
2017-06-05 2017-06-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 13 594 145 061 10,34 53,74 730 542 7 795 578
2017-05-02 2017-04-28 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
M - Exercise −28 320 0 −100,00
2017-05-02 2017-04-28 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −28 320 131 247 −17,75 119,50 −3 384 240 15 684 016
2017-05-02 2017-04-28 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 28 320 159 567 21,58 45,11 1 277 515 7 198 067
2017-02-15 2017-02-13 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −3 792 127 455 −2,89 88,39 −335 175 11 265 747
2017-02-07 2017-02-03 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
A - Award 24 852 24 852
2017-02-07 2017-02-03 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 12 136 131 247 10,19
2017-02-07 2017-02-03 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 5 753 119 111 5,08 0,01 58 1 191
2017-01-05 2017-01-03 4 CERU Cerulean Pharma Inc.
Common Stock
A - Award 7 467 13 104 132,46 0,77 5 750 10 090
2016-11-14 2016-11-09 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −1 208 113 358 −1,05 90,00 −108 720 10 202 220
2016-10-20 2016-10-03 4 CERU Cerulean Pharma Inc.
Common Stock
A - Award 5 637 5 637 1,02 5 750 5 750
2016-10-05 2016-10-03 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −1 208 114 566 −1,04 86,46 −104 444 9 905 376
2016-06-24 2016-06-22 4 CERU Cerulean Pharma Inc.
Stock Option (right to buy)
A - Award 20 000 20 000
2016-05-27 2016-05-25 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
G - Gift −150 115 774 −0,13
2016-02-04 2016-02-03 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −645 115 721 −0,55 92,80 −59 856 10 738 909
2016-02-04 2016-02-03 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −700 116 366 −0,60 91,89 −64 323 10 692 872
2016-02-04 2016-02-03 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −2 100 117 066 −1,76 90,98 −191 058 10 650 665
2016-02-04 2016-02-03 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −2 597 119 166 −2,13 89,92 −233 522 10 715 407
2016-02-04 2016-02-02 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
A - Award 34 482 34 482
2016-02-04 2016-02-02 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 17 299 121 763 16,56 0,01 173 1 218
2015-12-08 2015-12-04 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (right to buy)
M - Exercise −4 531 13 594 −25,00
2015-12-08 2015-12-04 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −100 104 464 −0,10 125,17 −12 517 13 075 759
2015-12-08 2015-12-04 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −2 252 104 564 −2,11 124,36 −280 059 13 003 579
2015-12-08 2015-12-04 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −2 179 106 816 −2,00 123,53 −269 172 13 194 980
2015-12-08 2015-12-04 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 4 531 108 995 4,34 53,74 243 496 5 857 391
2015-11-18 2015-11-16 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (right to buy)
M - Exercise −3 650 38 250 −8,71
2015-11-18 2015-11-16 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −3 650 104 464 −3,38 124,00 −452 600 12 953 536
2015-11-18 2015-11-16 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −100 108 114 −0,09 123,00 −12 300 13 298 022
2015-11-18 2015-11-16 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −143 108 214 −0,13 122,47 −17 513 13 252 969
2015-11-18 2015-11-16 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −184 108 357 −0,17 121,95 −22 439 13 214 136
2015-11-18 2015-11-16 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 3 650 108 541 3,48 77,31 282 182 8 391 305
2015-11-09 2015-11-05 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (right to buy)
M - Exercise −600 41 900 −1,41
2015-11-09 2015-11-05 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (right to buy)
M - Exercise −5 664 28 320 −16,67
2015-11-09 2015-11-05 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −200 104 748 −0,19 125,17 −25 034 13 111 307
2015-11-09 2015-11-05 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −1 220 104 948 −1,15 124,59 −152 000 13 075 471
2015-11-09 2015-11-05 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −2 400 106 168 −2,21 123,04 −295 296 13 062 911
2015-11-09 2015-11-05 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −2 444 108 568 −2,20 122,46 −299 292 13 295 237
2015-11-09 2015-11-05 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 600 111 012 0,54 77,31 46 386 8 582 338
2015-11-09 2015-11-05 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 5 664 110 412 5,41 45,11 255 503 4 980 685
2015-11-03 2015-10-30 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −4 500 104 748 −4,12 126,31 −568 395 13 230 720
2015-11-03 2015-10-30 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −3 950 109 248 −3,49 125,30 −494 935 13 688 774
2015-11-03 2015-10-30 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −1 000 113 198 −0,88 124,44 −124 440 14 086 359
2015-11-03 2015-10-30 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −900 114 198 −0,78 123,36 −111 024 14 087 465
2015-10-05 2015-10-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −600 115 098 −0,52 106,07 −63 642 12 208 445
2015-10-05 2015-10-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −5 058 115 698 −4,19 105,41 −533 164 12 195 726
2015-10-05 2015-10-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −5 159 120 756 −4,10 104,45 −538 858 12 612 964
2015-10-05 2015-10-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −900 125 915 −0,71 103,28 −92 952 13 004 501
2015-10-05 2015-10-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −700 126 815 −0,55 102,30 −71 610 12 973 174
2015-09-09 2015-09-04 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (right to buy)
M - Exercise −9 063 18 125 −33,33
2015-09-09 2015-09-04 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −3 463 127 515 −2,64 126,44 −437 862 16 122 997
2015-09-09 2015-09-04 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −5 200 130 978 −3,82 125,42 −652 184 16 427 261
2015-09-09 2015-09-04 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −400 136 178 −0,29 124,43 −49 772 16 944 629
2015-09-09 2015-09-04 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 9 063 136 578 7,11 53,74 487 046 7 339 702
2015-08-07 2015-08-05 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (right to buy)
M - Exercise −8 500 42 500 −16,67
2015-08-07 2015-08-05 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (right to buy)
M - Exercise −11 328 33 984 −25,00
2015-08-07 2015-08-05 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −2 300 127 515 −1,77 142,18 −327 014 18 130 083
2015-08-07 2015-08-05 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −13 328 129 815 −9,31 141,36 −1 884 046 18 350 648
2015-08-07 2015-08-05 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −4 200 143 143 −2,85 140,51 −590 142 20 113 023
2015-08-07 2015-08-05 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 8 500 147 343 6,12 77,31 657 135 11 391 087
2015-08-07 2015-08-05 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 11 328 138 843 8,88 45,11 511 006 6 263 208
2015-07-23 2015-07-21 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option
A - Award 34 000 34 000
2015-06-30 2015-06-26 4 CERU Cerulean Pharma Inc.
Stock Option (Right to Buy)
A - Award 22 000 22 000
2015-06-30 3 CERU Cerulean Pharma Inc.
No securities are beneficially owned.
0
2015-05-18 2015-05-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −148 127 515 −0,12 123,85 −18 330 15 792 733
2015-04-29 2015-04-27 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (right to buy)
M - Exercise −17 000 51 000 −25,00
2015-04-29 2015-04-27 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (right to buy)
M - Exercise −15 563 45 312 −25,57
2015-04-29 2015-04-27 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (right to buy)
M - Exercise −18 312 27 188 −40,25
2015-04-29 2015-04-27 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −700 127 515 −0,55 134,05 −93 835 17 093 386
2015-04-29 2015-04-27 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −3 400 128 215 −2,58 133,34 −453 356 17 096 188
2015-04-29 2015-04-27 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −6 316 131 615 −4,58 132,44 −836 491 17 431 091
2015-04-29 2015-04-27 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −4 230 137 931 −2,98 131,27 −555 272 18 106 202
2015-04-29 2015-04-27 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −11 321 142 161 −7,38 130,33 −1 475 466 18 527 843
2015-04-29 2015-04-27 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −1 100 153 482 −0,71 129,30 −142 230 19 845 223
2015-04-29 2015-04-27 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −12 933 154 582 −7,72 128,17 −1 657 623 19 812 775
2015-04-29 2015-04-27 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −21 480 167 515 −11,37 127,49 −2 738 485 21 356 487
2015-04-29 2015-04-27 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 17 000 188 995 9,88 77,31 1 314 270 14 611 203
2015-04-29 2015-04-27 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 15 563 171 995 9,95 45,11 702 047 7 758 694
2015-04-29 2015-04-27 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 18 312 156 432 13,26 53,74 984 087 8 406 656
2015-04-29 2015-04-27 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
G - Gift −150 138 120 −0,11
2015-02-05 2015-02-03 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (right to buy)
A - Award 68 000 68 000
2015-02-05 2015-02-03 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 20 700 138 270 17,61 0,01 207 1 383
2014-11-07 2014-11-05 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (right to buy)
M - Exercise −4 250 60 875 −6,53
2014-11-07 2014-11-05 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −300 117 264 −0,26 113,98 −34 194 13 365 751
2014-11-07 2014-11-05 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −1 374 117 564 −1,16 112,98 −155 235 13 282 381
2014-11-07 2014-11-05 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −2 576 118 938 −2,12 112,07 −288 692 13 329 382
2014-11-07 2014-11-05 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 4 250 121 514 3,62 45,11 191 718 5 481 497
2014-11-03 2014-10-30 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 75 000 117 264 177,46 0,01 750 1 173
2014-10-03 2014-10-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −100 42 264 −0,24 111,52 −11 152 4 713 281
2014-10-03 2014-10-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −400 42 364 −0,94 110,37 −44 148 4 675 715
2014-10-03 2014-10-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −900 42 764 −2,06 109,19 −98 271 4 669 401
2014-10-03 2014-10-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −4 037 43 664 −8,46 108,08 −436 319 4 719 205
2014-10-03 2014-10-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −5 373 47 701 −10,12 107,32 −576 630 5 119 271
2014-10-03 2014-10-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −1 607 53 074 −2,94 106,32 −170 856 5 642 828
2014-09-23 2014-09-19 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (right to buy)
M - Exercise −25 500 65 125 −28,14
2014-09-23 2014-09-19 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (right to buy)
M - Exercise −27 000 45 500 −37,24
2014-09-23 2014-09-19 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −55 521 54 681 −50,38 100,00 −5 552 100 5 468 100
2014-09-23 2014-09-19 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 25 500 110 202 30,11 45,11 1 150 305 4 971 212
2014-09-23 2014-09-19 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 27 000 84 702 46,79 53,74 1 450 980 4 551 885
2014-07-17 2014-07-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option
A - Award 34 000 34 000
2014-02-07 2014-02-05 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Employee Stock Option (right to buy)
A - Award 68 000 68 000
2014-02-07 2014-02-05 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 20 700 57 418 56,38 0,01 207 574
2013-12-12 2013-12-12 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −3 021 36 718 −7,60 65,47 −197 785 2 403 927
2013-10-03 2013-10-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −8 982 39 334 −18,59 76,49 −687 033 3 008 658
2013-10-03 2013-10-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −3 435 48 316 −6,64 75,73 −260 133 3 658 971
2013-08-01 2013-07-30 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option
A - Award 34 000 34 000
2013-07-31 2013-07-29 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X −347 51 751 −0,67 79,87 −27 715 4 133 352
2013-02-07 2013-02-05 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Employee Stock Option (right to buy)
A - Award 90 625 90 625
2013-02-07 2013-02-05 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 12 084 51 751 30,46 0,01 121 518
2012-09-06 2012-09-04 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Employee Stock Option (right to buy)
A - Award 72 500 72 500
2012-09-06 2012-09-04 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 30 000 39 667 310,33 0,01 300 397
2012-09-06 2012-09-04 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 9 667 9 667 0,01 97 97
P
Köp på öppna marknaden eller privat köp av icke-derivatsäkerhet
S
Köp på öppna marknaden eller privat försäljning av icke-derivatsäkerhet
A
Bevilja, tilldelning eller annat förvärv av värdepapper från företaget (såsom en option)
C
Omvandling av derivat
D
Försäljning eller överföring av värdepapper tillbaka til företaget
F
Betalning av lösenpris eller skatteskuld med del av värdepapper som erhållits från bolaget
G
Överlåtelse av värdepapper från eller till insidern
K
Aktieswappar och liknande säkringsaffärer
M
Utövande eller omvandling av derivatsäkerhet som erhållits från företaget (som en option)
V
En transaktion friviligt rapporterad på schema 4
J
Andra (med en fotnot som beskriver transaktionen)